George C. Butler
Keine laufenden Positionen mehr
Profil
George C.
Butler is a professional with a doctorate degree from The University of Manchester.
He is currently employed at Eversheds Sutherland Legal Services Ltd.
as of 2004.
Prior to this, he held positions at SingEval Pte Ltd.
as Chairman & President, Bionovo, Inc. as Director from 2008 to 2011, AstraZeneca PLC as VP-Customer Relationships & Global Development, and Novartis AG as Vice President & Head-Regulatory Affairs.
Ehemalige bekannte Positionen von George C. Butler
Unternehmen | Position | Ende |
---|---|---|
SingEval Pte Ltd.
SingEval Pte Ltd. BiotechnologyHealth Technology SingEval Pte Ltd. engages in pharmaceuticals services. The company is headquartered in Singapore. | Vorsitzender | 01.02.2009 |
ASTRAZENECA PLC | Public Communications Contact | 14.04.2011 |
NOVARTIS AG | General Counsel | - |
BIONOVO INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von George C. Butler
The University of Manchester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
NOVARTIS AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Bionovo, Inc.
Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA. | Health Technology |
SingEval Pte Ltd.
SingEval Pte Ltd. BiotechnologyHealth Technology SingEval Pte Ltd. engages in pharmaceuticals services. The company is headquartered in Singapore. | Health Technology |